Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 31, Issue 2, Pages e00079-17
Publisher
American Society for Microbiology
Online
2018-02-13
DOI
10.1128/cmr.00079-17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection
- (2018) Maddalena Giannella et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality
- (2017) M. Papadimitriou-Olivgeris et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Double-carbapenem combination as salvage therapy for untreatable infections by KPC-2-producing Klebsiella pneumoniae
- (2017) M. Souli et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015
- (2017) Te Din Huang et al. Eurosurveillance
- Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility
- (2017) Alexandre P. Zavascki et al. Expert Review of Anti-Infective Therapy
- Trimethoprim–sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series
- (2017) Rita Murri et al. INFECTION
- Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis
- (2017) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission
- (2017) Alexander Mischnik et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation
- (2017) Fiorella Krapp et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
- (2017) Rajnikant Sharma et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae
- (2017) Wei Yu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Role of piperacillin/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli
- (2017) Young Kyung Yoon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
- (2017) Juan J. Castón et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
- (2017) Anna Both et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value
- (2017) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae
- (2017) Miao Zhao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
- (2017) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1
- (2017) Yu-Feng Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia–Pacific countries: SMART 2013–2015
- (2017) James A. Karlowsky et al. JOURNAL OF MEDICAL MICROBIOLOGY
- The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
- (2017) Sung-Pin Tseng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India
- (2017) Laura E. B. Nabarro et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
- (2017) Hideo Kato et al. Drugs in research & development
- The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
- (2017) Jian Wang et al. Annals of Clinical Microbiology and Antimicrobials
- In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae
- (2017) Wei Yu et al. Frontiers in Cellular and Infection Microbiology
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
- (2017) Rong Zhang et al. EBioMedicine
- Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
- (2017) Ryan K. Shields et al. Open Forum Infectious Diseases
- Bloodstream infections caused byKlebsiella pneumoniaein onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey
- (2016) Enrico Maria Trecarichi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs
- (2016) P. Gagetti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
- (2016) A. Gomez-Simmonds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
- (2016) Tsukasa Ito-Horiyama et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae
- (2016) James Albiero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
- (2016) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae
- (2016) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plazomicin activity against 346 Extended-Spectrum-β-lactamase/AmpC-producing Escherichia coli urinary isolates, related to aminoglycoside-modifying enzymes characterized.
- (2016) Maria del Carmen López-Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association between the Presence of Aminoglycoside-Modifying Enzymes andIn VitroActivity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species
- (2016) Ghady Haidar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coexistence ofmcr-1andblaNDM-1in Escherichia coli from Venezuela
- (2016) Jose F. Delgado-Blas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- mcr-1.2, a NewmcrVariant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512
- (2016) Vincenzo Di Pilato et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global Dissemination ofblaKPCinto Bacterial Species beyond Klebsiella pneumoniae andIn VitroSusceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
- (2016) Krystyna M. Kazmierczak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms: a case series from the compassionate-use program
- (2016) Elizabeth Temkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
- (2016) Alexandre P. Zavascki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
- (2016) Takayuki Katsube et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency
- (2016) Visanu Thamlikitkul et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome
- (2016) Claudia M. D. de Maio Carrilho et al. BMC INFECTIOUS DISEASES
- Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
- (2016) Takahiko Fukuchi et al. BMC INFECTIOUS DISEASES
- Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
- (2016) Florian M. Wagenlehner et al. CLINICAL INFECTIOUS DISEASES
- The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
- (2016) Yael Dishon Benattar et al. CLINICAL INFECTIOUS DISEASES
- Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
- (2016) Laura J. Rojas et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
- (2016) John E. Mazuski et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae
- (2016) M. Falcone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
- (2016) A. Oliva et al. CLINICAL MICROBIOLOGY AND INFECTION
- Plasmid-mediated quinolone resistance: Two decades on
- (2016) José Manuel Rodríguez-Martínez et al. DRUG RESISTANCE UPDATES
- Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?
- (2016) Federico Perez et al. EXPERT OPINION ON PHARMACOTHERAPY
- Aminoglycoside Resistance
- (2016) Yohei Doi et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints
- (2016) Chih-Chia Hsieh et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases
- (2016) Polydoros Tofas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010–2013
- (2016) Shio-Shin Jean et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
- (2016) Konstantinos Z. Vardakas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections
- (2016) Michael P. Veve et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline
- (2016) Yunliang Zhang et al. JOURNAL OF ANTIBIOTICS
- Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
- (2016) Oren Zusman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producingEscherichia coli
- (2016) K. Alexandre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitropharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms
- (2016) Sherwin K. B. Sy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study
- (2016) Alexandre Brasseur et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producingKlebsiella pneumoniaein 24 hin vitrotime–kill experiments
- (2016) P. Lagerbäck et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A pharmacokinetic–pharmacodynamic model characterizing the emergence of resistantEscherichia colisubpopulations during ertapenem exposure
- (2016) Wanchana Ungphakorn et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae : a pooled analysis of Phase 3 clinical trials
- (2016) Myra W. Popejoy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
- (2016) Belén Gutiérrez-Gutiérrez et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections
- (2016) Mohamad-Ali Trad et al. JOURNAL OF CHEMOTHERAPY
- Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistantKlebsiella pneumoniaeandAcinetobacter baumanniiisolates and correlation with the molecular mechanism of resistance
- (2016) Shakti Laishram et al. JOURNAL OF CHEMOTHERAPY
- Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit
- (2016) I. Rossi Gonçalves et al. JOURNAL OF HOSPITAL INFECTION
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
- (2016) Zaira R. Palacios-Baena et al. JOURNAL OF INFECTION
- Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
- (2016) Yehuda Carmeli et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. MAYO CLINIC PROCEEDINGS
- Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
- (2016) Wentao Ni et al. MEDICINE
- Characterization of ST258 Colistin-Resistant,blaKPC-ProducingKlebsiella pneumoniaein a Greek Hospital
- (2016) Angeliki Mavroidi et al. Microbial Drug Resistance
- Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia
- (2016) Alejandro Díaz et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Treatment efficacy and superinfection rates in complicated urinarytract infections treated with ertapenem or piperacillin tazobactam
- (2016) Murat DİZBAY et al. Turkish Journal Of Medical Sciences
- Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and bla NDM-5 , Causing a Complicated Urinary Tract Infection in a Patient from the United States: TABLE 1
- (2016) José R. Mediavilla et al. mBio
- Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
- (2016) Yaakov Dickstein et al. BMJ Open
- Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae
- (2016) Wentao Ni et al. Frontiers in Microbiology
- Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
- (2016) Chang-Ro Lee et al. Frontiers in Microbiology
- Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock
- (2016) Nicolas Allou et al. Annals of Intensive Care
- Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia
- (2016) Jessica L. Elefritz et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Cefepime Therapy for Cefepime-Susceptible Extended-Spectrum β-Lactamase-ProducingEnterobacteriaceaeBacteremia: Table 1.
- (2016) Ruibin Wang et al. Open Forum Infectious Diseases
- Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
- (2016) Maria Virginia Villegas et al. PLoS One
- Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae
- (2016) Tat Ming Ng et al. PLoS One
- Combination Therapy against Polymicrobial Infection, Including by NDM-1-Producing Enterobacteriaceae Resistant to Colistin
- (2015) Itaru Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
- (2015) Brian C. Nelson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimizing the Initial Amikacin Dosage in Adults
- (2015) Bryan P. White et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
- (2015) Gabrielle A. Gibson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using anIn VitroInfection Model
- (2015) Brian D. VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates
- (2015) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
- (2015) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
- (2015) Douglas J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia
- (2015) Yasufumi Matsumura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli
- (2015) Shawn Vasoo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
- (2015) Hervé Dupont et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
- (2015) Jessica B. Cprek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
- (2015) Johann D. D. Pitout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
- (2015) Naoki Kohira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study
- (2015) Lidia Dalfino et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum -Lactamase Bacteremia
- (2015) P. D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- In vitro susceptibilities of clinical isolates of carbapenemase-producing Enterobacteriaceae to fosfomycin and tigecycline
- (2015) S. Choudhury et al. CLINICAL MICROBIOLOGY AND INFECTION
- Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins
- (2015) M.S. de Oliveira et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
- (2015) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- Association Between Colistin Dose and Development of Nephrotoxicity*
- (2015) Yu-Ji Lee et al. CRITICAL CARE MEDICINE
- Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
- (2015) Warren Lowman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases
- (2015) Krisztina M. Papp-Wallace et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread
- (2015) V. Weterings et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains
- (2015) Iciar Rodríguez-Avial et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments
- (2015) Mahableshwar S. Albur et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study
- (2015) Chen-Hsiang Lee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections
- (2015) Christina Routsi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs
- (2015) Fengcai Shen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection
- (2015) Shujuan Ji et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen
- (2015) Alessandra Oliva et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Synergistic killing of NDM-producing MDRKlebsiella pneumoniaeby two ‘old’ antibiotics—polymyxin B and chloramphenicol
- (2015) Nusaibah Abdul Rahim et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mutagenesis of the CTX-M-type ESBL—is MIC-guided treatment according to the new EUCAST recommendations a safe approach?
- (2015) João M. Costa Ramos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused byEnterobacter,CitrobacterorSerratiaspecies: a systematic review with meta-analysis
- (2015) Patrick N. A. Harris et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of temocillin in a murine model of urinary tract infection due toEscherichia coliproducing or not producing the ESBL CTX-M-15
- (2015) J. F. Soubirou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae
- (2015) Nathalie Grace Chua et al. JOURNAL OF INFECTION
- In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations
- (2015) Ayumi Yoshizumi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
- (2015) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan
- (2015) Yea-Yuan Chang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Extended-Spectrum β-Lactamase-ProducingEscherichia coliandKlebsiella pneumoniaeBacteremia in Febrile Neutropenic Children
- (2015) Seung Beom Han et al. Microbial Drug Resistance
- Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial
- (2015) Patrick NA Harris et al. Trials
- Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial
- (2015) Clara Rosso-Fernández et al. Trials
- High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
- (2015) Ali S Omrani et al. Annals of Clinical Microbiology and Antimicrobials
- Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum -lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial
- (2015) C. Rosso-Fernandez et al. BMJ Open
- Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains
- (2015) Noor A. Salloum et al. Frontiers in Microbiology
- Carbapenem-resistant Klebsiella pneumoniae infections in a Greek intensive care unit: Molecular characterisation and treatment challenges
- (2015) Maria Katsiari et al. Journal of Global Antimicrobial Resistance
- In vitro activities of colistin, tigecycline and tobramycin, alone or in combination, against carbapenem-resistant Enterobacteriaceae strains
- (2015) Berna Ozbek et al. Journal of Global Antimicrobial Resistance
- Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae
- (2015) Patrick N A Harris et al. Antimicrobial Resistance and Infection Control
- Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
- (2015) H. J. Morrill et al. Open Forum Infectious Diseases
- Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis
- (2015) Hui Yang et al. PLoS One
- Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
- (2015) Claudia Stein et al. PLoS One
- In VivoEfficacy of Humanized Exposures of Ceftazidime-Avibactam in Comparison with Ceftazidime against Contemporary Enterobacteriaceae Isolates
- (2014) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility of Characterized β-Lactamase-Producing Strains Tested with Avibactam Combinations
- (2014) Henry Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Doripenem, Gentamicin, and Colistin, Alone and in Combinations, against Gentamicin-Susceptible, KPC-Producing Klebsiella pneumoniae Strains with VariousompK36Genotypes
- (2014) Cornelius J. Clancy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
- (2014) Reem Almaghrabi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- UnexpectedIn VivoActivity of Ceftazidime Alone and in Combination with Avibactam against New Delhi Metallo-β-Lactamase-Producing Enterobacteriaceae in a Murine Thigh Infection Model
- (2014) Shawn H. MacVane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Doripenem MICs andompK36Porin Genotypes of Sequence Type 258, KPC-Producing Klebsiella pneumoniae May Predict Responses to Carbapenem-Colistin Combination Therapy among Patients with Bacteremia
- (2014) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae byIn VitroTime-Kill Experiments
- (2014) T. Tängdén et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis
- (2014) Paula Virginia Michelon Toledo et al. Brazilian Journal of Infectious Diseases
- In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae
- (2014) Y. Harada et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase–producing Proteus mirabilis
- (2014) Hsih-Yeh Tsai et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system
- (2014) Chulsoo Ahn et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Treatment of infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) Jesús Rodríguez-Baño et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients
- (2014) M. P. Freire et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae
- (2014) B. Pilmis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011
- (2014) M J Dautzenberg et al. Eurosurveillance
- Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
- (2014) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain
- (2014) Lorena López-Cerero et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
- (2014) Ilker Inanç Balkan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum -lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model
- (2014) G. G. Zhanel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials
- (2014) Shachaf Shiber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration
- (2014) P.-F. Laterre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections
- (2014) A. Oliva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae
- (2014) M. Gonzalez-Padilla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review
- (2014) K. Brust et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae
- (2014) D. van Duin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates
- (2014) P. Gaibani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-ProducingEscherichia Coli-Related Complicated Lower Urinary Tract Infection
- (2014) S. Senol et al. JOURNAL OF CHEMOTHERAPY
- Evaluation of antimicrobial combinations against colistin-resistant carbapenemase (KPC)-producingKlebsiella pneumoniae
- (2014) S. Maraki et al. JOURNAL OF CHEMOTHERAPY
- Characterization of carbapenem resistance mechanisms inKlebsiella pneumoniaeandin vitrosynergy of the colistin–meropenem combination
- (2014) Lakshmana Gowda Krishnappa et al. JOURNAL OF CHEMOTHERAPY
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
- (2014) Thomas P Van Boeckel et al. LANCET INFECTIOUS DISEASES
- To B or Not to B, That Is the Question: Is It Time to Replace Colistin With Polymyxin B?
- (2014) Zahra Kassamali et al. PHARMACOTHERAPY
- Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae
- (2014) Ziad Daoud et al. Journal of Infection in Developing Countries
- The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli
- (2014) Na Wu et al. Annals of Clinical Microbiology and Antimicrobials
- Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis Model
- (2013) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli
- (2013) Pilar Retamar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems
- (2013) Jae H. Hong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of Ceftazidime-Avibactam and Aztreonam-Avibactam against 372 Gram-Negative Bacilli Collected in 2011 and 2012 from 11 Teaching Hospitals in China
- (2013) Xiaojuan Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Tigecycline in Combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-Producing Enterobacteriaceae in a Murine Thigh Infection Model
- (2013) George Michail et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Humanized Carbapenem Exposures against New Delhi Metallo-β-Lactamase (NDM-1)-Producing Enterobacteriaceae in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model
- (2013) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic Activity of Colistin plus Rifampin against Colistin-Resistant KPC-Producing Klebsiella pneumoniae
- (2013) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
- (2013) Matthew E. Falagas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ertapenem use with Impact Assessment on Extended-Spectrum Beta-Lactamases (ESBL) Production and Gram-Negative resistance in Singapore General Hospital (SGH)
- (2013) Cheryl Li-Ling Lim et al. BMC INFECTIOUS DISEASES
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae
- (2013) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin
- (2013) K. van Dijk et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evaluating amikacin dosage regimens in intensive care unit patients: A pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation
- (2013) Hinojal Zazo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria
- (2013) Konstantinos Pontikis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy
- (2013) M. L. Mezzatesta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu
- (2013) J. Dominguez-Herrera et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia
- (2013) C.-H. Liao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs
- (2013) M. Hagihara et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase
- (2013) N. Woodford et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-resistantKlebsiella pneumoniaesepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination
- (2013) Hayati Demiraslan et al. JOURNAL OF CHEMOTHERAPY
- Activity of the colistin–rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria
- (2013) Marcela Nastro et al. JOURNAL OF CHEMOTHERAPY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients
- (2013) B. Balandin Moreno et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- KPC - 3 Klebsiella pneumoniaeST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients
- (2013) Paola Di Carlo et al. BMC Anesthesiology
- Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
- (2012) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill
- (2012) Ami F. Mohamed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
- (2012) Vicki L. Collins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
- (2012) Meredith G. Jernigan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
- (2012) Teena Chopra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Broad-Spectrum β-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due to Klebsiella pneumoniae Producing the Carbapenemase OXA-48
- (2012) Olivier Mimoz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model
- (2012) Kamilia Abdelraouf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniaein patients on maintenance hemodialysis
- (2012) Chih-Chao Yang et al. BMC INFECTIOUS DISEASES
- Epidemic of Klebsiella pneumoniae ST11 Clone Coproducing KPC-2 and 16S rRNA Methylase RmtB in a Chinese University Hospital
- (2012) Jun-Jie Li et al. BMC INFECTIOUS DISEASES
- Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
- (2012) Giulia Vicari et al. CLINICAL INFECTIOUS DISEASES
- Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC Matters
- (2012) Nan-Yao Lee et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- Frequent detection of plasmid-mediated quinolone resistance (qnr) genes in multidrug-resistant Enterobacteriaceae blood isolates, Hong Kong
- (2012) C. C. Lee et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002–2010
- (2012) Chi-Chang Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
- (2012) Asako Doi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
- (2012) K. Z. Vardakas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases
- (2012) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
- (2012) J. R. Pano-Pardo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model
- (2012) L. Jakobsen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae
- (2012) Elizabeth B. Hirsch et al. JOURNAL OF INFECTIOUS DISEASES
- Ertapénem intraveineux ou sous-cutané pour le traitement des infections urinaires à entérobactérie sécrétrice de BLSE
- (2012) E. Forestier et al. MEDECINE ET MALADIES INFECTIEUSES
- In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
- (2011) Maria Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase
- (2011) Dora E. Wiskirchen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimization of Aminoglycoside Therapy
- (2011) G. L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Effectiveness of Aminoglycosides, Polymyxin B, and Tigecycline for Clearance of Carbapenem-Resistant Klebsiella pneumoniae from Urine
- (2011) Michael J. Satlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective, Non-Interventional, Multi-Centre Trial of Tigecycline in the Treatment of Severely Ill Patients with Complicated Infections – New Insights into Clinical Results and Treatment Practice
- (2011) Christian Eckmann et al. CHEMOTHERAPY
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
- (2011) J. Rodriguez-Bano et al. CLINICAL INFECTIOUS DISEASES
- Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?
- (2011) F. Perez et al. CLINICAL INFECTIOUS DISEASES
- Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
- (2011) O. Zarkotou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
- (2011) G.L. Daikos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli
- (2011) J. Rodríguez-Baño et al. CLINICAL MICROBIOLOGY AND INFECTION
- Colistin: new lessons on an old antibiotic
- (2011) D. Yahav et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dosing of colistin—back to basic PK/PD
- (2011) Phillip J Bergen et al. CURRENT OPINION IN PHARMACOLOGY
- Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli or Klebsiella pneumoniae
- (2011) Nan-Yao Lee et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae
- (2011) George A. Pankey et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
- (2011) G. Samonis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Pharmacokinetic and pharmacodynamic evaluation of tigecycline
- (2011) Helen Giamarellou et al. Expert Opinion on Drug Metabolism & Toxicology
- Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
- (2011) Matthew E Falagas et al. Future Microbiology
- What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- (2011) David M. Livermore et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence
- (2011) David P. Nicolau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ertapenem in the treatment of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli: a propensity score analysis
- (2011) Un-In Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Efficacy and safety of tigecycline: a systematic review and meta-analysis
- (2011) Dafna Yahav et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
- (2011) B. Bercot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
- (2011) D. E. Karageorgopoulos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae
- (2011) Indran Balakrishnan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
- (2011) Efthimia Tasina et al. LANCET INFECTIOUS DISEASES
- Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children
- (2011) Nazan Dalgic et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Worldwide Experience with the Use of Doripenem against Extended-Spectrum- -Lactamase-Producing and Ciprofloxacin-Resistant Enterobacteriaceae: Analysis of Six Phase 3 Clinical Studies
- (2010) K. Kaniga et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease
- (2010) Yun Cai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroEffect ofqnrA1,qnrB1, andqnrS1Genes on Fluoroquinolone Activity against IsogenicEscherichia coliIsolates with Mutations ingyrAandparC
- (2010) A. Briales et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftazidime and NXL104 in Two Murine Models of Infection Due to KPC-ProducingKlebsiella pneumoniae
- (2010) Andrea Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
- (2010) C. C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
- (2010) C. A. DeRyke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes
- (2010) Yong Pil Chong et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
- (2010) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of carbapenems against a metallo- -lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model
- (2010) M. Souli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum- -lactamase-producing Gram-negative organisms
- (2010) R. Bazaz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
- (2010) A. Elemam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli
- (2009) J. M. Adams-Haduch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Characteristics of Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates Causing Bacteremia in the Calgary Health Region from 2000 to 2007: Emergence of Clone ST131 as a Cause of Community-Acquired Infections
- (2009) J. D. D. Pitout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection
- (2009) N. Allou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Does the Activity of the Combination of Imipenem and Colistin In Vitro Exceed the Problem of Resistance in Metallo- -Lactamase-Producing Klebsiella pneumoniae Isolates?
- (2009) M. Souli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
- (2009) D. Plachouras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of NXL104 in Combination with -Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases
- (2009) A. Endimiani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.
- (2009) L. López-Cerero et al. CLINICAL MICROBIOLOGY AND INFECTION
- AmpC -Lactamases
- (2009) G. A. Jacoby CLINICAL MICROBIOLOGY REVIEWS
- A review of tigecycline — the first glycylcycline
- (2009) Lance R. Peterson INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
- (2009) Olaf Burkhardt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
- (2009) C. Gudiol et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
- (2009) T. Stachyra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
- (2009) Garyphallia Poulakou et al. JOURNAL OF INFECTION
- Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum -lactamase
- (2009) D. Skurnik et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Breakpoints for extended-spectrum β-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations
- (2008) A. MacGowan CLINICAL MICROBIOLOGY AND INFECTION
- Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1
- (2008) J.M. Rodríguez-Martínez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Polymyxins Revisited
- (2008) D. Landman et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical significance of extended-spectrum β-lactamases
- (2008) Jesús Rodríguez-Baño et al. Expert Review of Anti-Infective Therapy
- Emergence of imipenem resistance in clinical Escherichia coli during therapy
- (2008) Jesús Oteo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam
- (2008) Johann D.D. Pitout et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
- (2008) K. Vasilev et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
- (2008) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
- Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 β-lactamase–producing Klebsiella pneumoniae epidemic clone
- (2007) Javier Cobo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More